These include nausea (affecting 15-44% of users depending on dose), diarrhea (10-30%), vomiting (7-25%), constipation (6-24%), and abdominal pain or discomfort (approximately 9%)
Completely eliminating fat increases the risk of gallstones during rapid weight loss
Notch activation induces apoptosis in neural progenitor cells through a p53-dependent pathway
How liraglutide and semaglutide are used in weight management Though originally developed for patients with type 2 diabetes, GLP-1 receptor agonists are now FDA-approved for weight management in adults with a body mass index (BMI) of 30 or higher, or 27 or higher with weight related health conditions
Contrary to the intestinal tissue, the liver is characterized by a strong expression of Bhmt and Cbs enzymes, which contribute alternative pathways within one-carbon metabolism (74)